Milan

Italy

2,361 total trials 1,025 recruiting

Filter these 2,361 trials by phase, condition, sponsor and more.

Open in Search →

Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLL … Ended recruitment

2024-520050-38-00 5 2025-09-18 Extensive stage small cell lung cancer (ES-SCLC). S
A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Pharmacodynamics, Clinical Effects, and Safety between ABP 692 … Ended recruitment

2024-512914-16-00 5 2025-09-12 Relapsing-remitting Multiple Sclerosis
A study to assess the efficacy and safety of Empasiprubart versus IVIg in adults with Multifocal Motor Neuropathy Ended recruitment

2024-516473-72-00 5 2025-07-31 Multifocal Motor Neuropathy
A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Ended recruitment

2024-519773-19-00 5 2025-07-31 Gastroesophageal Junction Adenocarcinoma
A Study to Compare Risankizumab to Vedolizumab in Adult Subjects With Moderate to Severe Ulcerative Colitis Ended recruitment

2024-518998-33-00 5 2025-07-23 Ulcerative Colitis
A Study to Evaluate Tobevibart+Elebsiran versus Bulevirtide in Chronic HDV Infection Ended recruitment

2024-520062-54-00 4 2025-07-23 Chronic Hepatitis D Virus (HDV) Infection
A clinical study of sotatercept in people with pulmonary arterial hypertension Ended recruitment

2024-518687-12-00 4 2025-06-19 Pulmonary Arterial Hypertension (PAH)
Phase 1b/2 Study of Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Participants With Advanced Gastric Cancer (Substudy GC) Ended recruitment

2024-517817-34-00 9 2025-06-18 Gastric Cancer
Evaluation of the safety and efficacy of the drug Veonetinib (AL8326) in the post-first treatment of small cell lung cancer, non small cell … Ended recruitment

2023-509067-24-01 4 2025-06-17 - Small Cell Lung Cancer (SCLC) patients who need ≥2nd line treatment
Study of Zelenectide Pevedotin in Participants with Advanced Breast Cancer Ended recruitment

2024-517868-33-00 4 2025-06-12 NECTIN4 Amplified Advanced Breast Cancer
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARIT … Ended recruitment

2024-515523-11-00 5 2025-06-09 Chronic Weight Management
Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced NSCLC (Substudy NSCLC) Ended recruitment

2024-517818-15-00 9 2025-06-06 Non-Small Cell Lung Cancer
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MA … Ended recruitment

2024-515524-36-00 5 2025-05-30 Chronic Weight Management
A Phase 3 study to assess the efficacy, safety, and tolerability of itepekimab (antiIL33 mAb) in participants with inadequately-controlled … Ended recruitment

2024-516815-26-00 5 2025-05-30 Chronic rhinosinusitis with nasal polyps
A Phase 2, Multi-Center, Randomized, Double-Blind, Controlled Trial Evaluating the Safety and Efficacy of ENV-101 in Patients with Lung Fibr … Ended recruitment

2024-511754-41-00 4 2025-05-29 idiopathic pulmonary fibrosis
A study to test different doses of BI 1831169 alone and in combination with an anti-PD-1 antibody in people with different types of advanced … Ended recruitment

2024-512504-19-00 1 2025-05-28 solid tumors
A Phase 3 study to assess efficacy, safety and tolerability of remibrutinib in adult and adolescent patients with moderate to severe hidrade … Ended recruitment

2024-513282-39-00 5 2025-05-28 Hidradenitis Suppurativa (HS)
Phase 2 Pan-Tumor Trial of R-DXd for Advanced/Metastatic Solid Tumors Ended recruitment

2024-513307-13-00 4 2025-05-26 Advanced/metastatic solid tumors including gynecological cancers (endo
A Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Atopic Dermatitis Ended recruitment

2024-515494-95-00 4 2025-05-26 Moderate to Severe Atopic Dermatitis (AD)
A randomised, double-blind, placebo-controlled, two-part study to evaluate the pharmacokinetics, safety and tolerability, and preliminary ef … Ended recruitment

2024-515907-20-00 9 2025-05-23 Primary biliary cholangitis (PBC)
A Phase 3 study to assess the efficacy, safety, and tolerability of itepekimab (antiIL33 mAb) in participants with inadequately-controlled … Ended recruitment

2024-516814-39-00 5 2025-05-20 Chronic rhinosinusitis with nasal polyps
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole in People Over 18 Years of Age With HR-Positive, … Ended recruitment

2024-512925-95-00 5 2025-05-16 Advanced/Metastatic Breast Cancer
Phase 2 Study of CVN424 Ended recruitment

2024-516811-25-00 4 2025-05-15 Parkinson Disease
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Subjects With Progressive Metastatic Castration- … Ended recruitment

2024-513968-25-00 5 2025-04-28 Metastatic castration-resistant prostate cancer (mCRPC)

Showing 1,225–1,248 of 2,361 trials